Company page
G2gbio, Inc.
G2gbio, Inc. is a public company listed under the ticker 456160, operating in the Korean market. The company has a market capitalization of approximately 481.27 million USD. G2gbio focuses on biotechnology and related sectors, contributing to advancements in healthcare and medical solutions.
- Ticker
- 456160:KRX
- Asset type
- Stock
- Market cap
- $481.3M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW